Soo Chin Lee

Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study

Sandra M. Swain, David Miles, Sung‐Bae Kim et al. · The Lancet Oncology · 2020 · 898 citations

Medicine, Oncology, Pharmacology +14

Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells

Majid Ebrahimi Warkiani, Guofeng Guan, Khoo Bee Luan et al. · Lab on a Chip · 2013 · 579 citations · Full text

Engineering, Bioengineering, Biomedical Engineering +17

IFI16-dependent STING signaling is a crucial regulator of anti-HER2 immune response in HER2+ breast cancer

L.S. Ong, Wee Chyan Lee, Shijun Ma et al. · Proceedings of the National Academy of Sciences · 2022 · 567 citations · Full text

Life Sciences, Immunology, Oncology +17

Neratinib Plus Paclitaxel vs Trastuzumab Plus Paclitaxel in Previously Untreated Metastatic ERBB2-Positive Breast Cancer: The NEfERT-T Randomized Clinical Trial

Feng Xu, Ahmad Awada, Rámón Colomer et al. · UNC Libraries · 2020 · 486 citations · Full text

Medicine, Oncology, Pharmacology +12

The genomic landscape of nasopharyngeal carcinoma

De‐Chen Lin, Xuan Meng, Masaharu Hazawa et al. · Nature Genetics · 2014 · 376 citations

Medicine, Genetics, Molecular Genetics +14